Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vandetanib as a potential treatment for breast cancer.
De Luca A, D'Alessio A, Maiello MR, Gallo M, Bevilacqua S, Frezzetti D, Morabito A, Perrone F, Normanno N. De Luca A, et al. Among authors: d alessio a, frezzetti d. Expert Opin Investig Drugs. 2014 Sep;23(9):1295-303. doi: 10.1517/13543784.2014.942034. Epub 2014 Aug 4. Expert Opin Investig Drugs. 2014. PMID: 25089348 Review.
FGFR-targeted therapeutics for the treatment of breast cancer.
De Luca A, Frezzetti D, Gallo M, Normanno N. De Luca A, et al. Among authors: frezzetti d. Expert Opin Investig Drugs. 2017 Mar;26(3):303-311. doi: 10.1080/13543784.2017.1287173. Epub 2017 Feb 6. Expert Opin Investig Drugs. 2017. PMID: 28121208 Review.
VEGF as a potential target in lung cancer.
Frezzetti D, Gallo M, Maiello MR, D'Alessio A, Esposito C, Chicchinelli N, Normanno N, De Luca A. Frezzetti D, et al. Among authors: d alessio a. Expert Opin Ther Targets. 2017 Oct;21(10):959-966. doi: 10.1080/14728222.2017.1371137. Epub 2017 Aug 30. Expert Opin Ther Targets. 2017. PMID: 28831824 Review.
Pharmacokinetic drug evaluation of palbociclib for the treatment of breast cancer.
De Luca A, Maiello MR, D'Alessio A, Frezzetti D, Gallo M, Carotenuto M, Normanno N. De Luca A, et al. Among authors: frezzetti d. Expert Opin Drug Metab Toxicol. 2018 Sep;14(9):891-900. doi: 10.1080/17425255.2018.1514720. Epub 2018 Sep 3. Expert Opin Drug Metab Toxicol. 2018. PMID: 30130984 Review.
Genomic Profiling of KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer Patients Reveals Novel Mutations in Genes Potentially Associated with Resistance to Anti-EGFR Agents.
Rachiglio AM, Lambiase M, Fenizia F, Roma C, Cardone C, Iannaccone A, De Luca A, Carotenuto M, Frezzetti D, Martinelli E, Maiello E, Ciardiello F, Normanno N. Rachiglio AM, et al. Among authors: frezzetti d. Cancers (Basel). 2019 Jun 20;11(6):859. doi: 10.3390/cancers11060859. Cancers (Basel). 2019. PMID: 31226844 Free PMC article.
19 results